DnB Asset Management AS Sells 390 Shares of DaVita Inc. (NYSE:DVA)

DnB Asset Management AS cut its stake in shares of DaVita Inc. (NYSE:DVA) by 4.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,070 shares of the company’s stock after selling 390 shares during the quarter. DnB Asset Management AS’s holdings in DaVita were worth $1,356,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. SBI Securities Co. Ltd. bought a new stake in DaVita during the 4th quarter valued at about $41,000. Quarry LP bought a new stake in shares of DaVita during the third quarter valued at approximately $60,000. Venturi Wealth Management LLC raised its holdings in DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after acquiring an additional 152 shares during the last quarter. Versant Capital Management Inc lifted its position in DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares in the last quarter. Finally, Blue Trust Inc. boosted its stake in DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after purchasing an additional 131 shares during the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on DVA shares. Barclays boosted their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research note on Friday, February 21st. Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, StockNews.com downgraded shares of DaVita from a “buy” rating to a “hold” rating in a research report on Wednesday. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, DaVita has an average rating of “Hold” and a consensus price target of $166.33.

DaVita Trading Down 0.7 %

DaVita stock opened at $151.82 on Wednesday. The business has a 50-day simple moving average of $156.77 and a two-hundred day simple moving average of $157.44. DaVita Inc. has a 52-week low of $125.64 and a 52-week high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The company has a market cap of $12.15 billion, a P/E ratio of 14.14, a P/E/G ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last announced its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.